“Health donors, policymakers, and practitioners continuously make life-and-death decisions about which type of patients receive what interventions, when, and at what cost. These decisions—as consequential as they are— often result from ad hoc, nontransparent processes driven more by inertia

iDSI aims to help policymakers in low and middle income countries in building capacity for active priority-setting, such that they can spend limited health budgets in a more efficient and equitable way, and achieve sustainable universal health coverage (UHC). In order to help achieve iDSI this aim,

Rapeepong Suphanchaimat1,2 Angkana Sommanustweechai1 , Chiraporn Khitdee1 , Chompoonut Thaichinda1 , Kanang Kantamaturapoj3 , Pattara Leelahavarong4 , Pensom Jumriangrit1 , Thitikorn Topothai1 , Thunthita Wisaijohn1 Weerasak Putthasri1 1International Health Policy Program (IHPP), Ministry of Publi

Development cannot be contained in a numerical measure of Gross National Product/Gross Domestic Product (GNP/GDP), conceding this the UN gave a universal call to its member nations for the Sustainable Development Goals (SDGs). The SDG 3 explicitly states “ensuring healthy lives and promote well-bein

COVID-19 disease models have aided policymakers in low-and middle-income countries (LMICs) with many critical decisions. Many challenges remain surrounding their use, from inappropriate model selection and adoption, inadequate and untimely reporting of evidence, to the lack of iterative stakeholder

Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Rob Baltussen1, Sitapon Youngkong11,2, Francesco Paolucci3, Louis Niessen4 1 Department of Primary and Community Care, Radboud University Nijmegen Medical Center, The Netherlands 2 Health I

Background Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Vaccination is a critical and cost-effective public health intervention that significantly reduces child mortality. Since the inception of the World Health Organization’s Expanded Program on Immunization (WHO-EPI) in 1974, vaccines have saved millions of lives, with a Lancet study highlighting that

The Thai Innovation List was established in 2015 to compile products and services developed through Thailand’s scientific and technological knowledge and research capacity. The initiative was designed to support and promote the utilization of Thai innovations for economic development and commercialization. Medical innovations account for approxim